▎ VIAL TRUST REPORTLast evaluated July 8, 2026
Vial Score
Limited data: few signals on recordgetvial.com/report/telyrx67/100
Limited public record on fileVial Score over time
50 (May 31) → 67 (Jul 8) · 7 snapshots
Scoring method updated: a Vial change, not a provider change.
8 of 9 applicable signals confirmed
We confirmed 8 of 9 checks that apply to a telehealth platform. One we couldn't independently verify — ask the provider directly.
WHAT WE CONFIRMED
- —
WHAT WE COULDN'T VERIFY
- Physician oversight not publicly disclosed
- Pricing not publicly disclosed
- LegitScript certification not confirmed
Where this score differs
How TelyRx compares with similar providers Vial tracks.
Before you pay, ask
Questions to bring to TelyRx before committing.
- 01Which pharmacy compounds and ships my medication, and is it PCAB accredited?
- 02What is the all-in monthly cost — including consult, prescription, and shipping?
- 03Which physician will prescribe my medication, and in which states are they licensed?
- 04What is the cancellation policy and what happens to my prescription if I stop?
Share
WHAT THIS MEANS
Many telehealth platforms operate under contracted physician NPIs rather than a corporate NPI. Absence of a corporate NPI is common for this category and not, on its own, a red flag.
No FDA enforcement actions are on record for this provider in the public openFDA database.
Some legitimate providers — particularly newer brands and small practices — have minimal public records. This isn't proof of risk, but it does mean trust has to be established directly with the provider rather than via federal databases.
REPORT HISTORY▸ Latest: Jul 8 2026 · Vial scoring enhancement
May 31, 2026
Vial score established · 50/100
Jun 01, 2026 · SCORING ENHANCEMENT
Vial scoring enhancement
Scores were recalculated under an evidence-weighted model: a provider's score now reflects how much Vial has verified, so thinly-documented records sit near the neutral baseline instead of reaching the extremes. Lab credentials (CLIA/CAP) were added as positive evidence, a verified-clean US federal record (FDA/OIG/DEA) now counts toward regulatory standing for US-based providers (a clean US screen is not credited to an overseas provider that those registries would never list), every scored dimension holds a consistent neutral baseline where Vial has not yet verified it, and grey-market vendors are flagged. This is a Vial scoring change, not a change at the provider.
Jun 05, 2026
Score decreased 30 pts → 26/100
Jun 17, 2026
Score increased 38 pts → 64/100
Jun 28, 2026
Score increased 7 pts → 71/100
Jul 08, 2026 · SCORING ENHANCEMENT
Vial scoring enhancement
Scores were recalculated under a refined model, in two steps the same day. Verified federal screens now weigh how recently they were checked, and a verified physician network earns additional credit when its clinicians are confirmed in the federal NPI registry. A named pharmacy partner is now weighed by whether Vial has independently verified that specific relationship, rather than by how the partner was described. Two inputs that reflected a naming convention or an unverifiable claim were removed from scoring. Missing information continues to lower how much Vial has verified, never the score itself. This is a Vial scoring change, not a change at the provider.
WHEN WE LAST CHECKED
FDA2026-06-03
OIG2026-07-06
DEA2026-07-06
HIPAA2026-07-06
NPI2026-07-06
PCAB2026-06-04
Are you TelyRx?
Claim this profile to add disclosures, or dispute findings with documentation.
Want us to watch TelyRx for you?
Strong today doesn't mean strong forever. We'll email you if anything changes:
- A new enforcement action appears
- Their Vial Score moves
- Their pharmacy partner changes
- Complaint patterns emerge
Free. We’ll only email when something actually changes.